MINI FUTURE SHORT - RESMED | Market Closed - Börse Stuttgart 02:46:58 2024-07-01 pm EDT | ||
| 3.33 EUR | +15.62% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
| Date | Price | Change |
|---|---|---|
| 24-07-01 | 3.33 | +15.63% |
| 24-06-28 | 2.88 | -2.37% |
| 24-06-27 | 2.95 | -13.99% |
Delayed Quote Börse Stuttgart
Last update July 01, 2024 at 02:46 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RESMED, INC. |
| Issuer | Morgan Stanley |
| WKN | MG6L0L |
| ISIN | DE000MG6L0L4 |
| Date issued | 2024-06-26 |
| Strike | 222.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.75 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.6 € |
|---|---|
| Lowest since issue | 2.76 € |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
186.9
USD
Average target price
220.4
USD
Spread / Average Target
+17.91%
- Stock Market
- Certificates
- Certificat
